Ferraro, Richard A.
Leucker, Thorsten
Martin, Seth S.
Banach, Maciej
Jones, Steven R.
Toth, Peter P. http://orcid.org/0000-0001-5810-5460
Article History
Accepted: 17 February 2022
First Online: 18 March 2022
Declarations
:
: No external funding was used in the preparation of this manuscript.
: RAF, none. TL, grants from the American Heart Association Career Development Award (19CDA34760040), the Johns Hopkins Center for AIDS Research (P30AI094189 and 1704611701), the Johns Hopkins Older Americans Independence Center (P30AG021334), and Amgen. SSM has served as a consultant Quest Diagnostics, Sanofi/Regeneron, Amgen, and the Pew Research Center. MB, speakers bureau: Amgen, Daichii Sankyo, Herbapol, Kogen, KRKA, Mylan, Novartis, Novo-Nordisk, Polpharma, Sanofi, Servier, Teva, Zentiva; consultant to Amgen, DaichiiSankyo, Esperion, Freia Pharmaceuticals, Mylan, Polfarmex, Sanofi/Regeneron, Teva; Grants from Amgen, Mylan, Sanofi, and Valeant. SSM and SRJ are listed as coinventors on a pending patent filed by Johns Hopkins University for LDL-C estimation. SRJ has served as an advisor to Sanofi/Regeneron. PPT, speaker’s bureau: Amarin, Amgen, Esperion, Novo-Nordisk; Consultant: Amarin, Esperion, Kowa, Merck, Resverlogix, Theravance.
: RAF and PPT conceptualized and wrote the manuscript; TL, MB, SSM, and SRJ provided important scientific and clinical feedback and assisted with editing and finalizing the manuscript.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
Free to read: This content has been made available to all.